Cargando…

Intranasal Vaccination Promotes Detrimental Th17-Mediated Immunity against Influenza Infection

Influenza disease is a global health issue that causes significant morbidity and mortality through seasonal epidemics. Currently, inactivated influenza virus vaccines given intramuscularly or live attenuated influenza virus vaccines administered intranasally are the only approved options for vaccina...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maroof, Asher, Yorgensen, Yvonne M., Li, Yufeng, Evans, Jay T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3900655/ https://www.ncbi.nlm.nih.gov/pubmed/24465206 http://dx.doi.org/10.1371/journal.ppat.1003875

Ejemplares similares

Intranasal vaccination with influenza HA/GO-PEI nanoparticles provides immune protection against homo- and heterologous strains
por: Dong, Chunhong, et al.
Publicado: (2021)

Local Th17/IgA immunity correlate with protection against intranasal infection with Streptococcus pyogenes
por: Mortensen, Rasmus, et al.
Publicado: (2017)

Selenium supplementation has beneficial and detrimental effects on immunity to influenza vaccine in older adults
por: Ivory, Kamal, et al.
Publicado: (2017)

Intranasal Vaccination with an Engineered Influenza Virus Expressing the Receptor Binding Subdomain of Botulinum Neurotoxin Provides Protective Immunity Against Botulism and Influenza
por: Li, Junwei, et al.
Publicado: (2015)

Human immune responses elicited by an intranasal inactivated H5 influenza vaccine
por: Ainai, Akira, et al.
Publicado: (2020)

Intranasal immunization with outer membrane vesicle pertussis vaccine confers broad protection through mucosal IgA and Th17 responses
por: Raeven, René H. M., et al.
Publicado: (2020)

Detrimental impact of allergic airway disease on live attenuated influenza vaccine
por: Roy, Sreeja, et al.
Publicado: (2021)

Protective Intranasal Immunization Against Influenza Virus in Infant Mice Is Dependent on IL-6
por: Bonney, Elizabeth Ann, et al.
Publicado: (2020)

A Dual Adjuvant System for Intranasal Boosting of Local and Systemic Immunity for Influenza Vaccination
por: Sato-Kaneko, Fumi, et al.
Publicado: (2022)

Acceptability of intranasal live attenuated influenza vaccine, influenza knowledge and vaccine intent in The Gambia
por: Armitage, Edwin P., et al.
Publicado: (2018)

Intranasal H5N1 Vaccines, Adjuvanted with Chitosan Derivatives, Protect Ferrets against Highly Pathogenic Influenza Intranasal and Intratracheal Challenge
por: Mann, Alex J., et al.
Publicado: (2014)

Respiratory PCR detects influenza after intranasal live-attenuated influenza vaccination
por: Lumley, S, et al.
Publicado: (2013)

Comparative onset of immunity of oral and intranasal vaccines against challenge with Bordetella bronchiseptica
por: Scott-Garrard, Maya M, et al.
Publicado: (2018)

Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses
por: Mao, Tianyang, et al.
Publicado: (2022)

NKT Cell Stimulation with α-Galactosylceramide Results in a Block of Th17 Differentiation after Intranasal Immunization in Mice
por: Zygmunt, Beata M., et al.
Publicado: (2012)

Broadly Neutralizing Antibodies for Influenza: Passive Immunotherapy and Intranasal Vaccination
por: Biswas, Mrityunjoy, et al.
Publicado: (2020)

Intranasal influenza vaccination using a new synthetic mucosal adjuvant SF‐10: induction of potent local and systemic immunity with balanced Th1 and Th2 responses
por: Kimoto, Takashi, et al.
Publicado: (2013)

Intranasal Flu Vaccine Protective against Seasonal and H5N1 Avian Influenza Infections
por: Alsharifi, Mohammed, et al.
Publicado: (2009)

Intranasal powder live attenuated influenza vaccine is thermostable, immunogenic, and protective against homologous challenge in ferrets
por: Luczo, Jasmina M., et al.
Publicado: (2021)

Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs
por: Dhakal, Santosh, et al.
Publicado: (2018)

Partial Protective Effect of Intranasal Immunization with Recombinant Toxoplasma gondii Rhoptry Protein 17 against Toxoplasmosis in Mice
por: Wang, Hai-Long, et al.
Publicado: (2014)

Intranasal Delivery of Influenza Subunit Vaccine Formulated with GEM Particles as an Adjuvant
por: Saluja, Vinay, et al.
Publicado: (2010)

Intranasal Delivery of Cholera Toxin Induces Th17-Dominated T-Cell Response to Bystander Antigens
por: Lee, Jee-Boong, et al.
Publicado: (2009)

Preclinical Evaluation of TB/FLU-04L—An Intranasal Influenza Vector-Based Boost Vaccine against Tuberculosis
por: Shurygina, Anna-Polina, et al.
Publicado: (2023)

High Antigen Dose Is Detrimental to Post-Exposure Vaccine Protection against Tuberculosis
por: Billeskov, Rolf, et al.
Publicado: (2018)

Interleukin (IL)-12 and IL-18 Synergize to Promote MAIT Cell IL-17A and IL-17F Production Independently of IL-23 Signaling
por: Cole, Suzanne, et al.
Publicado: (2020)

Intradermal Vaccination against Influenza with a STING-Targeted Nanoparticle Combination Adjuvant Induces Superior Cross-Protective Humoral Immunity in Swine Compared with Intranasal and Intramuscular Immunization
por: Hernandez-Franco, Juan F., et al.
Publicado: (2023)

Lymphocytes are detrimental during the early innate immune response against Listeria monocytogenes
por: Carrero, Javier A., et al.
Publicado: (2006)

Potentiating Lung Mucosal Immunity Through Intranasal Vaccination
por: Nelson, Sean A., et al.
Publicado: (2021)

Antigen-specific memory Th17 cells promote cross-protection against nontypeable Haemophilus influenzae after mild influenza A virus infection
por: Zhang, Xinyun, et al.
Publicado: (2023)

Multiple-Clade H5N1 Influenza Split Vaccine Elicits Broad Cross Protection against Lethal Influenza Virus Challenge in Mice by Intranasal Vaccination
por: Yang, Penghui, et al.
Publicado: (2012)

2554. Safety and Immunogenicity of NasoVAX, a Novel Intranasal Influenza Vaccine
por: Tasker, Sybil, et al.
Publicado: (2018)

Intranasal Vaccination With Lipoproteins Confers Protection Against Pneumococcal Colonisation
por: Voß, Franziska, et al.
Publicado: (2018)

The mucosal and systemic immune responses elicited by a chitosan‐adjuvanted intranasal influenza H5N1 vaccine
por: Svindland, Signe C., et al.
Publicado: (2011)

Simultaneous Subcutaneous and Intranasal Administration of a CAF01-Adjuvanted Chlamydia Vaccine Elicits Elevated IgA and Protective Th1/Th17 Responses in the Genital Tract
por: Wern, Jeanette Erbo, et al.
Publicado: (2017)

Herd immunity communication counters detrimental effects of selective vaccination mandates: Experimental evidence
por: Sprengholz, Philipp, et al.
Publicado: (2020)

Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2
por: An, Xingyue, et al.
Publicado: (2021)

Intranasal Vaccination with Outer-Membrane Protein of Orientia tsutsugamushi induces Protective Immunity Against Scrub Typhus
por: Park, Sung-Moo, et al.
Publicado: (2020)

The Role of Neutrophils in the Induction of Specific Th1 and Th17 during Vaccination against Tuberculosis
por: Trentini, Monalisa M., et al.
Publicado: (2016)

The efficacy of a 2,4-diaminoquinazoline compound as an intranasal vaccine adjuvant to protect against influenza A virus infection in vivo
por: Noh, Kyungseob, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_503metpp9kt7lcvl3l9d5ol41s